U receives $5.4M to address medicine shortages

The U’s Center for Infectious Disease Research and Policy (CIDRAP) has received a $5.4 million gift from the Walton Family Foundation to address global drug and medical supply shortages. 

CIDRAP’s work will focus on the supply chains and global disruptions for drugs that provide lifesaving and life-sustaining treatment, with the goal of improving the system’s ability to maintain a steady and adequate supply of these critical medications and supplies worldwide. CIDRAP is a global leader in addressing public health preparedness and emerging infectious disease response.

Unexpected yet significant shortages in medical supplies are often due to manufacturing disruptions caused by natural disasters or breakdowns in infrastructure. The disruption makes entire communities vulnerable, especially during public health disasters. 

“We know, based on our recent experience, that there will be more and more incidents where necessary drugs or medical supplies will be unavailable to those in crisis and, increasingly, the consequences are truly about life and death,” says CIDRAP director Michael T. Osterholm, Ph.D., M.P.H., who will colead the team with Amy Kircher, Dr.P.H., codirector of the U’s Strategic Partnerships and Research Collaborative.  

Published on April 3, 2019